BIO Ventures for Global Health
BVGH strategically develops and manages programs across the for-profit and non-profit sectors to catalyze innovative research and development (R&D); expand research and healthcare capacity in low- and middle-income countries (LMICs); and increase access to high-quality health care.
Our Programs
African Access Initiative (AAI)
Driven by Africa, for Africa – leveraging public-private partnerships to target the growing cancer crisis.
African Consortium for Cancer Clinical Trials (AC3T)
Building cancer clinical trial capacity in Africa.
Global Innovation Alliance (GIA)
Advancing health equity by reducing the burden of infectious diseases.
“The role of industry in improving global health cannot be understated. We have been, and must continue to be, leaders, experts, innovators, and—most importantly—partners in global efforts to reduce suffering and the burden of disease”
Mr. James Greenwood,
Past President & CEO, Biotechnology Innovation Organization (BIO);
Chairman, BVGH Board of Directors; USA
OUR IMPACT
$2m
Worth of cancer medicines allocated through AAI
48
Hospitals in our Network
185+
R&D Collaborations facilitated since 2011
CURRENT TRAINING COURSES
Click the flyer to register for each course
LATEST NEWS
Closing the Cancer Care Gap in Africa
Cancer in AfricaAfrica and other low- and middle-income regions are collectively responsible for 70% of the global cancer burden. Africa faces a 67% mortality-to-incidence ratio from cancer according to recent statistics released by the World Health Organization’s International Agency for Research on Cancer (IARC). Compare this number to the 23% touted by Northern America, and…
Keep reading
Researchers in Germany and Nigeria Join Forces to Differentiate Febrile Diseases with New Diagnostics
In sub-Saharan Africa and other regions with high burdens of malaria, patients presenting with fevers are often prescribed antimalarial drugs without a confirmed diagnosis to avoid treatment delays. However, many infectious diseases cause fevers, and inappropriate use of antimalarial medicines for patients who do not have malaria fuels development of drug resistance. While malaria diagnostic…
Keep reading
Network for Africa’s Clinical Trials Community Established
BVGH is thrilled to be part of the Clinical Trials Community Africa Network project, a bold step towards a coordinated and sustainable clinical trials network in Africa. This joint effort with Global Health EDCTP; Science for Africa Foundation; Fondation Mérieux; Medicines Development for Global Health; The Janssen Pharmaceutical Companies of Johnson & Johnson; and nuvoteQ.io…
Keep reading
Loading…
Something went wrong. Please refresh the page and/or try again.